F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
Based on interview, record review, and facility policy review, the facility failed to ensure one (Resident 1) of
three sampled residents was free from unnecessary drugs when facility's interdisciplinary team (IDT) did
not re-evaluate use of Seroquel (an antipsychotic medication) at the time of admission and/ or within two
weeks for its appropriateness and indication for use to consider whether or not the medication could be
reduced, tapered, or discontinued. Interdisciplinary team is a group of healthcare professionals who work
together to treat a patient condition.
This failure had the potential for Resident 1 to receive unnecessary medications and placed her at risk to
suffer adverse effects from the medication.
Findings:
During a review of Resident 1's admission Record (AR), dated 12/23/24, the AR indicated, Resident 1 was
admitted from acute care hospital on 8/22/24.
During a review of Resident 1's Admission-Minimum Data Set (MDS- Resident Assessment and care guide
tool) dated 8/26/24, the MDS indicated Resident 1 had no potential indicators of psychosis e.g.,
hallucinations (perceptual experiences in the absence of real external sensory stimuli) or delusions
(misconceptions or beliefs that are firmly held, contrary to reality). MDS indicated Resident 1 had no
physical or verbal behavioral symptoms directed towards others e.g., verbal/vocal symptoms like screaming
or disruptive sounds, hitting, kicking, pushing, scratching, or grabbing at others. MDS indicated Resident 1's
diagnosis included chronic obstructive pulmonary disease with acute exacerbation (COPD-a worsening
group of lung diseases that block airflow and make it difficult to breathe).
During a review of Resident 1's Order Summary Report dated 8/22/24, indicated the physician prescribed
Resident 1 Seroquel oral tablet 25 mg give one tablet by mouth at bedtime for mood disorder manifested by
yelling and hitting for 14 days. Further review of Resident 1's Order Summary Reports dated 9/3/24 and
9/18/24, indicated physician continued prescribing Resident 1 Seroquel oral tablet 25 mg, to give one tablet
by mouth at bedtime for mood disorder manifested by yelling and screaming.
During a review of Resident 1's Medication Administration Record (MAR), dated 8/23/24 to 8/31/24 and
9/1/24 to 9/18/24, the MARs indicated Resident 1 was administered Seroquel 25 mg give one tablet by
mouth at bedtime for yelling, hitting and screaming.
During an interview on 12/23/24 at 11:17 a.m. with Certified Nursing Assistant (CNA) 1, CNA1 stated CNA1
cared for Resident 1 four days a week. CNA1 stated Resident 1 had behavior of calling out for
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
555914
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555914
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/31/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
We Care Skilled Nursing Facility
21863 Vallejo Street
Hayward, CA 94541
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
help from time to time. CNA1 stated when Resident 1 was asked what she needed, Resident 1 said
nothing.
During an interview on 12/27/24 at 11:29 a.m. with Licensed Vocational Nurse (LVN 1), LVN 1 stated
Resident 1 was prescribed Seroquel from Resident 1 stay at the hospital. LVN 1 stated Resident 1 had
COPD, was on oxygen therapy. LVN 1 stated Resident 1 had anxiety behavior when she had problem with
breathing and inability to relax; she would call out for help.
During an interview on 12/27/24 at 11:37 a.m. Licensed Vocational Nurse (LVN 2), LVN 2 stated Resident 1
was nice and cooperative. LVN 2 stated Resident 1 sometimes had anxiety and called out for help.
During a review of Resident 1's Consultant Pharmacist's Medication Regimen Review (MRR), dated
8/27/24, the MRR indicated, Resident 1 had an order for Seroquel 25 mg at bedtime for 14 days. If the drug
is to be continued beyond its initial 14-day period, you may wish to ask if the dose could be reduced to 12.5
mg at bedtime . mood disorder is not a usual diagnosis for an antipsychotic, If continued beyond 14 days
please clarify diagnosis .
During a concurrent interview and record review on 12/31/24 at 10:16 a.m. with the Director of Nursing
(DON), Resident 1's progress notes, care plan use of antipsychotic, MRR dated 8/27/24 and facility's policy
and procedure (P&P) titled, Antipsychotic Medication Use were reviewed. The DON stated facility did not
reevaluate Resident 1's use of Seroquel medication at the time of admission or within two weeks of her
admission to the facility, to consider reduction or discontinuation. The DON stated she was unable to find
documentation if facility followed up on pharmacist's recommendations made on 8/27/24.
During a review of the facility's policy and procedure (P&P) titled, Antipsychotic Medication Use, revised
July 2022, the P&P indicated, Residents who are admitted from the community or transferred from a
hospital and who are already receiving antipsychotic medications will be evaluated for the appropriateness
and indications for use. The interdisciplinary team will re-evaluate the use of the antipsychotic medication at
the time of admission and / or within two weeks (at the initial MDS assessment) to consider whether or not
the medication can be reduced, tapered, discontinued.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555914
If continuation sheet
Page 2 of 2